CBLL

CeriBell, Inc. - Common Stock (CBLL)

About CeriBell, Inc. - Common Stock (CBLL)

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Details

Daily high
$23.40
Daily low
$22.62
Price at open
$23.40
52 Week High
$25.63
52 Week Low
$10.85
Market cap
901.1M
Dividend yield
-
Volume
243,793
Avg. volume
348,607
P/E ratio
-13.34

CeriBell, Inc. - Common Stock News

Details

Daily high
$23.40
Daily low
$22.62
Price at open
$23.40
52 Week High
$25.63
52 Week Low
$10.85
Market cap
901.1M
Dividend yield
-
Volume
243,793
Avg. volume
348,607
P/E ratio
-13.34